[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346565-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-346565-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","tumor-microenvironment-dynamics-in-gastric-cancer-pathogenesis-and-therapeutic-resistance","Tumor microenvironment dynamics in gastric cancer pathogenesis and therapeutic resistance","","Gastric cancer remains a major global health challenge with high incidence and mortality, particularly in advanced disease where treatment options are limited. Its pathogenesis and therapeutic resistance are driven by a highly heterogeneous tumor microenvironment (TME) shaped by genetic mutations and chronic inflammation. The TME includes immune, myeloid, stromal, extracellular matrix, and peripheral nerve components that promote immune evasion, tumor progression, and therapy refractoriness. Mechanisms such as angiogenesis, fibrosis, and metabolic reprogramming further enable resistance. The review highlights emerging TME-targeted strategies and advances like single-cell sequencing and spatial transcriptomics to support personalized treatment.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/tumor-microenvironment-dynamics-in-gastric-cancer-pathogenesis-and-therapeutic-resistance/346565/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/tumor-microenvironment-dynamics-in-gastric-cancer-pathogenesis-and-therapeutic-resistance/346565.png","ImageObject",300,407,{"name":42,"@type":43},"Olivia Brown","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-08","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does the tumor microenvironment influence gastric cancer pathogenesis and resistance?","Question",{"text":63,"@type":64},"The TME affects tumor initiation and progression and contributes to therapeutic resistance by enabling immune evasion, remodeling the extracellular matrix, and supporting growth and metastasis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which components of the TME are highlighted as key players?",{"text":68,"@type":64},"The review emphasizes tumor-infiltrating lymphocytes; myeloid-lineage cells such as tumor-associated macrophages and myeloid-derived suppressor cells; cancer-associated fibroblasts; extracellular matrix; and peripheral nerves.",{"name":70,"@type":61,"acceptedAnswer":71},"What therapeutic strategies are proposed to overcome gastric cancer therapy resistance?",{"text":72,"@type":64},"Strategies include modulating immune components, inhibiting fibrosis, normalizing angiogenesis, and disrupting metabolic pathways. The review also points to enhanced understanding from single-cell sequencing and spatial transcriptomics.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},346565,1790936852,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Lu et al. Molecular Cancer (2026) 25:58 Molecular Cancer  \n[https://doi.org/10.1186/s12943-026-02572-2](https://doi.org/10.1186/s12943-026-02572-2)  \nRESEARCH Open Access  \nTumor microenvironment dynamics in gastric cancer pathogenesis and therapeutic resistance  \nZhenhua Lu1†, Qinnan Zhang1†, Jing Han1†, Jiafu Ji1,2* and Xiaofang Xing1,2*  \nAbstract  \nGastric cancer remains a significant global health challenge due to its high incidence and mortality, and limited treatment options in advanced stages. Notably, gastric cancer exhibits a complex tumor microenvironment (TME) with substantial cellular and spatial heterogeneity, which profoundly impacts disease pathogenesis and therapeutic resistance. Genetic mutations and chronic inflammation contribute to its development by promoting abnormal cell proliferation and creating an immunosuppressive TME. The TME comprises various cellular and acellular components—including tumor-infiltrating lymphocytes, myeloid lineage cells such as tumor-associated macrophages and myeloid-derived suppressor cells, cancer-associated fibroblasts, extracellular matrix, and peripheral nerves—that interact with cancer cells, influencing tumor initiation, progression, immune evasion, and resistance to therapy. These elements modulate immune responses, remodel the extracellular matrix, and facilitate tumor growth and metastasis, thereby adding to the complexity of the TME. Moreover, the TME plays a critical role in therapeutic resistance through mechanisms involving angiogenesis, fibrosis, and metabolic reprogramming. Understanding the dynamic interactions within the TME offers opportunities to develop novel therapeutic strategies. Emerging approaches targeting the TME—including modulation of immune components, inhibition of fibrosis, normalization of angiogenesis, and disruption of metabolic pathways—hold promise in overcoming therapeutic resistance. Advances in technologies such as single-cell sequencing and spatial transcriptomics further enhance our understanding ofTME heterogeneity, paving the way for personalized medicine in gastric cancer treatment. This review summarized the current knowledge of the cellular and molecular composition of the TME of gastric cancer, its role in disease pathogenesis and therapy resistance, and explores potential therapeutic strategies targeting TME components.  \nKeywords Gastric cancer, Tumor microenvironment, Immune evasion, Metabolic reprogramming, Therapeutic resistance  \n†Zhenhua Lu, Qinnan Zhang and Jing Han contributed equally to this work.  \n*Correspondence:  \nJiafu Ji [jijiafu@hsc.pku.edu.cn](jijiafu@hsc.pku.edu.cn)[ ](jijiafu@hsc.pku.edu.cn)Xiaofang Xing [Xingxiaofang@bjmu.edu.cn](Xingxiaofang@bjmu.edu.cn)  \n1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Cancer Translational Research Laboratory, Peking University Cancer Hospital & Institute, Beijing 100142, China  \n2State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing 100142, People’s Republic of China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the ar","cbCaillzMYKy4dKW","https://ap.wps.com/l/cbCaillzMYKy4dKW","pdf",4104347,33,"English","# Abstract\n## Background\n## Tumor microenvironment and resistance mechanisms\n## Emerging TME-targeted therapeutic strategies","[{\"question\":\"How does the tumor microenvironment influence gastric cancer pathogenesis and resistance?\",\"answer\":\"The TME affects tumor initiation and progression and contributes to therapeutic resistance by enabling immune evasion, remodeling the extracellular matrix, and supporting growth and metastasis.\"},{\"question\":\"Which components of the TME are highlighted as key players?\",\"answer\":\"The review emphasizes tumor-infiltrating lymphocytes; myeloid-lineage cells such as tumor-associated macrophages and myeloid-derived suppressor cells; cancer-associated fibroblasts; extracellular matrix; and peripheral nerves.\"},{\"question\":\"What therapeutic strategies are proposed to overcome gastric cancer therapy resistance?\",\"answer\":\"Strategies include modulating immune components, inhibiting fibrosis, normalizing angiogenesis, and disrupting metabolic pathways. The review also points to enhanced understanding from single-cell sequencing and spatial transcriptomics.\"}]","Tumor microenvironment dynamics in gastric cancer pathogenesis and therapeutic resistance | PDF",1790061991,83,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b5647d1df48367882e3b7ecec0725f7.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e99711c214e7de45218f20b18468c43f.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fbc048598cec1ac6f03ac42584d75a85.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/65a74652458c4d375112424602bf5b54.webp",980,1306]